Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H16N2O2.ClH |
Molecular Weight | 244.718 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
InChI
InChIKey=RNAICSBVACLLGM-GNAZCLTHSA-N
InChI=1S/C11H16N2O2.ClH/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2;/h5,7-8,10H,3-4,6H2,1-2H3;1H/t8-,10-;/m0./s1
Molecular Formula | C11H16N2O2 |
Molecular Weight | 208.2569 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:14:43 UTC 2023
by
admin
on
Fri Dec 15 15:14:43 UTC 2023
|
Record UNII |
0WW6D218XJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
62091
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8806
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | Merck Index | ||
|
0WW6D218XJ
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
5909
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
C748
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
200-212-5
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
SUB14870MIG
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
DBSALT000307
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
CHEMBL550
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
141029
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
1538902
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
235426
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID2041096
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
PILOCARPINE HYDROCHLORIDE
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odourless or almost odourless. Solubility: Very soluble in water; freely soluble in ethanol (~750 g/l) TS; insoluble in ether R. Category: Parasympathomimetic; miotic. Storage: Pilocarpine hydrochloride should be kept in a tightly closed container, protected from light. Additional information: Pilocarpine hydrochloride is very poisonous; it is hygroscopic and is affected by light. Even in the absenceof light, Pilocarpine hydrochloride is gradually degraded on exposure to a humid atmosphere, the decomposition being faster athigher temperatures. Definition: Pilocarpine hydrochloride contains not less than 98.5% and not more than 101.0% of C11H16N2O2,HCl, calculated withreference to the dried substance. | ||
|
0WW6D218XJ
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
54-71-7
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY | |||
|
100000091736
Created by
admin on Fri Dec 15 15:14:43 UTC 2023 , Edited by admin on Fri Dec 15 15:14:43 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
PARENT -> SALT/SOLVATE |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
sum of impurities A and B: not more than 3 times the area of the principal peak in the chromatogram obtained with reference solution (a) (1.5 per cent)
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Other | PHARMACOKINETIC |
|
Cmax PHARMACOKINETIC |
|
||
Other | PHARMACOKINETIC |
|
Doses PHARMACOKINETIC |
|
||